According to an article recently published in The Vancouver Sun, the birth control pills Yaz and Yasmin, manufactured by Bayer, have been linked to the deaths of 23 women in…
Read More
In June 2012, Johnson & Johnson made the decision to remove their defective transvaginal mesh (TVM) medical device from the global market. Though the medical device manufacturer cites future market…
Read More
Published May 8, 2012 on TMD A loophole in federal law requires the FDA to approve some previously-recalled medical devices. Now, the agency says it wants to see that changed.…
Read More
Published May 7, 2012 on LawsuitInformation.org Settlements for plaintiffs who have experienced serious side effects associated with the popular birth control medications Yaz and Yasmin have reached into the millions,…
Read More
Posted February 29, 2012 by LawsuitInformation.org Alleges Pfizer hid birth defect risks to pregnant mothers prescribed the antidepressant ST. LOUIS, Feb 06, 2012 (BUSINESS WIRE) — St. Louis–based law firm…
Read More
In the United Kingdom, the Department of Health and the Medicines and Healthcare Products Regulatory Agency (MHRA) have been collaborating on a safety review of transvaginal mesh. Their collaborative effort…
Read More
Though medical devices are developed to improve lives, such is not always the case when discussing transvaginal mesh products. Used to treat stress urinary incontinence (SUI) and pelvic organ prolapse…
Read More
On March 3, 2015, the Food and Drug Administration began requiring drug makers to caution patients that testosterone medications may escalate the risk of heart attacks and strokes. The FDA…
Read More
Posted March 16, 2012 by LawsuitInformation.org Suit asserts Pfizer hid risks of birth defects when the antidepressant was taken during pregnancy ST. LOUIS–(BUSINESS WIRE)–St. Louis–based law firm Carey Danis &…
Read More
In current Levaquin lawsuit news, it has become apparent that fluoroquinolones, like Levaquin (levofloxacin), is the cause of more than just tendon damage, as previously understood. In a recent New…
Read More